XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 18 $ 141,612 $ (119,419) $ 22,211
Begining balance, shares at Dec. 31, 2020 18,410,458      
Equity compensation 1,632 1,632
Issuance of shares for vested restricted stock grants
Issuance of shares for vested restricted stock grants, shares 8,915      
Net loss (5,461) (5,461)
Exercise of stock options, net of cashless exercise of 58,122 shares and 92,634 shares withheld $ 1 1,755 1,756
Exercise of stock options, net of cashless exercise of shares, shares 206,545      
Exercise of warrants 20 20
Exercise of warrants, shares 9,000      
Ending balance, value at Jun. 30, 2021 $ 19 145,019 (124,880) 20,158
Ending balance, shares at Jun. 30, 2021 18,634,918      
Beginning balance, value at Mar. 31, 2021 $ 18 144,302 (124,044) 20,276
Begining balance, shares at Mar. 31, 2021 18,593,757      
Equity compensation 651 651
Issuance of shares for vested restricted stock grants
Issuance of shares for vested restricted stock grants, shares 7,161      
Net loss (836) (836)
Exercise of stock options, net of cashless exercise of 58,122 shares and 92,634 shares withheld $ 1 46 47
Exercise of stock options, net of cashless exercise of shares, shares 25,000      
Exercise of warrants 20 20
Exercise of warrants, shares 9,000      
Ending balance, value at Jun. 30, 2021 $ 19 145,019 (124,880) 20,158
Ending balance, shares at Jun. 30, 2021 18,634,918      
Beginning balance, value at Dec. 31, 2021 $ 19 146,455 (126,897) 19,577
Begining balance, shares at Dec. 31, 2021 18,660,369      
Equity compensation 1,349 1,349
Issuance of shares for vested restricted stock grants
Issuance of shares for vested restricted stock grants, shares 215,211      
Net loss (2,566) (2,566)
Ending balance, value at Jun. 30, 2022 $ 19 147,804 (129,463) 18,360
Ending balance, shares at Jun. 30, 2022 18,875,580      
Beginning balance, value at Mar. 31, 2022 $ 19 147,284 (128,365) 18,938
Begining balance, shares at Mar. 31, 2022 18,674,980      
Equity compensation 520 520
Issuance of shares for vested restricted stock grants
Issuance of shares for vested restricted stock grants, shares 200,600      
Net loss (1,098) (1,098)
Ending balance, value at Jun. 30, 2022 $ 19 $ 147,804 $ (129,463) $ 18,360
Ending balance, shares at Jun. 30, 2022 18,875,580